Verma, Atul

Approaches to catheter ablation for persistent atrial fibrillation

Verma, A., Jiang, C.-Y., Betts, T. R., Chen, J., Deisenhofer, I., Mantovan, R., Macle, L., Morillo, C. A., Haverkamp, W., Weerasooriya, R., et al. (2015) · New England Journal of Medicine

Atrial Fibrillation Management and OutcomesCardiac Arrhythmias and Treatments

Cited by 2,339

Radiofrequency Ablation vs Antiarrhythmic Drugs as First-line Treatment of Symptomatic Atrial Fibrillation: A Randomized Trial

Wazni, O. M., Marrouche, N. F., Martin, D. O., Verma, A., Bhargava, M., Saliba, W., Bash, D., Schweikert, R., Brachmann, J., Gunther, J., et al. (2005) · JAMA

Atrial Fibrillation Management and OutcomesCardiac Arrhythmias and Treatments

Cited by 1,121

Radiofrequency Ablation vs Antiarrhythmic Drugs as First-Line Treatment of Paroxysmal Atrial Fibrillation (RAAFT-2): A Randomized Trial

Morillo, C. A., Verma, A., Connolly, S. J., Kuck, K. H., Nair, G. M., Champagne, J., Sterns, L. D., Beresh, H., Healey, J. S., Natale, A., et al. (2014) · JAMA

Atrial Fibrillation Management and OutcomesCardiac Arrhythmias and Treatments

Cited by 667

Progression of Atrial Fibrillation after Cryoablation or Drug Therapy

Andrade, J. G., Deyell, M. W., Macle, L., Wells, G. A., Bennett, M., Essebag, V., Champagne, J., Roux, J.-F., Yung, D., Skanes, A., et al. (2023) · New England Journal of Medicine

Atrial Fibrillation Management and OutcomesCardiac Arrhythmias and Treatments

Cited by 385

Discerning the Incidence of Symptomatic and Asymptomatic Episodes of Atrial Fibrillation Before and After Catheter Ablation (DISCERN AF): A Prospective, Multicenter Study

Verma, A., Champagne, J., Sapp, J., Essebag, V., Novak, P., Skanes, A., Morillo, C. A., Khaykin, Y., & Birnie, D. (2013) · JAMA Internal Medicine

Atrial Fibrillation Management and OutcomesCardiac Arrhythmias and Treatments

Cited by 315

Adenosine-guided pulmonary vein isolation for the treatment of paroxysmal atrial fibrillation: an international, multicentre, randomised superiority trial

Macle, L., Khairy, P., Weerasooriya, R., Novak, P., Verma, A., Willems, S., Arentz, T., Deisenhofer, I., Veenhuyzen, G., Scavée, C., et al. (2015) · The Lancet

Atrial Fibrillation Management and OutcomesCardiac Arrhythmias and Treatments

Cited by 226

Feasibility and Safety of Uninterrupted Rivaroxaban for Periprocedural Anticoagulation in Patients Undergoing Radiofrequency Ablation for Atrial Fibrillation

Lakkireddy, D., Reddy, Y. M., Di Biase, L., Vallakati, A., Mansour, M. C., Santangeli, P., Gangireddy, S., Swarup, V., Chalhoub, F., Atkins, D., et al. (2014) · Journal of the American College of Cardiology

Atrial Fibrillation Management and OutcomesCardiac Arrhythmias and Treatments

Cited by 177

Left Septal Atrial Flutter: Electrophysiology, Anatomy, and Results of Ablation

Marrouche, N. F., Natale, A., Wazni, O. M., Cheng, J., Yang, Y., Pollack, H., Verma, A., Ursell, P., & Scheinman, M. M. (2004) · Circulation

Cardiac Arrhythmias and TreatmentsAtrial Fibrillation Management and Outcomes

Cited by 110

Substrate and Trigger Ablation for Reduction of Atrial Fibrillation Trial-Part II (STAR AF II): design and rationale

Verma, A., Sanders, P., Macle, L., Deisenhofer, I., Morillo, C. A., Chen, J., Jiang, C.-Y., Ernst, S., & Mantovan, R. (2012) · American Heart Journal

Atrial Fibrillation Management and OutcomesCardiac Arrhythmias and Treatments

Cited by 57

Dofetilide is safe and effective in preventing atrial fibrillation recurrences in patients accepted for catheter ablation

Shamiss, Y., Khaykin, Y., Oosthuizen, R., Tunney, D., Sarak, B., Beardsall, M., Seabrook, C., Frost, L., Wulffhart, Z., Tsang, B., et al. (2009) · EP Europace

Atrial Fibrillation Management and OutcomesCardiac Arrhythmias and Treatments

Cited by 17